Camp4 Therapeutics's Suppliers recorded an increase in sales by 15.83 % year on year in Q2 2026, sequentially sales grew by 8.03 %, while their net profit margin fell to 2.78 % year on year, compared to the previous quarter Camp4 Therapeutics's Suppliers had a lower net margin at 8.03 %,
Camp4 Therapeutics's Suppliers recorded an increase in sales by 15.83 % year on year in Q2 2026, sequentially sales grew by 8.03 %, while their net profit margin fell to 2.78 % year on year, compare to previous quarter CAMP's Suppliers had lower net margin at 2.78 %,
While the vast majority of our products are designed in the United States, we
currently outsource a substantial portion of our manufacturing to certain contract
manufacturers, which are located primarily in Hong Kong, mainland China, Malaysia
and other Pacific Rim countries. Our electronic devices, components and made-to-order
assemblies used in our products can be obtained from these manufacturers, although
certain components are obtained from sole source suppliers. Although we do not
have any long-term purchase contracts, we have executed product supply agreements
with these manufacturers which provide for certain product quality requirements.
We are not vertically integrated, which provides us with flexibility and an ability
to adapt to changes in the market, product supply and pricing while keeping our
fixed costs low. Our relationships with our manufacturers are critical to new
product introduction and the success of our business. We have strong relationships
with our manufacturers, helping us meet our supply and support requirements.
We focus on driving alignment of our product roadmaps with our manufacturers
and determining what we can do collectively to reduce costs across the supply
chain. Our operations team based in the United States coordinates with our manufacturers’
engineers and quality control personnel to develop the requisite manufacturing
processes, quality checks and testing as well as general oversight of the manufacturing
activities. We believe this model has allowed us to effectively deliver high
quality and innovative products while enabling us to minimize costs, manage
inventory risk and maintain flexibility.
Camp4 Therapeutics's Comment on Supply Chain
While the vast majority of our products are designed in the United States, we
currently outsource a substantial portion of our manufacturing to certain contract
manufacturers, which are located primarily in Hong Kong, mainland China, Malaysia
and other Pacific Rim countries. Our electronic devices, components and made-to-order
assemblies used in our products can be obtained from these manufacturers, although
certain components are obtained from sole source suppliers. Although we do not
have any long-term purchase contracts, we have executed product supply agreements
with these manufacturers which provide for certain product quality requirements.
We are not vertically integrated, which provides us with flexibility and an ability
to adapt to changes in the market, product supply and pricing while keeping our
fixed costs low. Our relationships with our manufacturers are critical to new
product introduction and the success of our business. We have strong relationships
with our manufacturers, helping us meet our supply and support requirements.
We focus on driving alignment of our product roadmaps with our manufacturers
and determining what we can do collectively to reduce costs across the supply
chain. Our operations team based in the United States coordinates with our manufacturers’
engineers and quality control personnel to develop the requisite manufacturing
processes, quality checks and testing as well as general oversight of the manufacturing
activities. We believe this model has allowed us to effectively deliver high
quality and innovative products while enabling us to minimize costs, manage
inventory risk and maintain flexibility.
CAMP's Suppliers Net profit fell by
CAMP's Suppliers Net margin fell in Q2 to
-74.12 %
2.78 %
CAMP's Suppliers Net profit fell by -74.12 %
CAMP's Suppliers Net margin fell in Q2 to 2.78 %
Camp4 Therapeutics's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Camp4 Therapeutics Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Camp4 Therapeutics Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
4.89 % 